CHARLES SCHWAB INVESTMENT MANAGEMENT INC - VITAE PHARMACEUTICALS INC ownership

VITAE PHARMACEUTICALS INC's ticker is VTAE and the CUSIP is 92847N103. A total of 98 filers reported holding VITAE PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 2.35 and the average weighting 0.4%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of VITAE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2016$1,779,000
+104.0%
85,017
+5.2%
0.00%
+100.0%
Q2 2016$872,000
+294.6%
80,791
+143.4%
0.00%
Q1 2016$221,000
-62.5%
33,189
+1.9%
0.00%
-100.0%
Q4 2015$590,000
+94.7%
32,577
+18.7%
0.00%
Q3 2015$303,000
-19.6%
27,449
+5.1%
0.00%
-100.0%
Q2 2015$377,000
+121.8%
26,118
+80.5%
0.00%
Q1 2015$170,000
-25.4%
14,466
+5.9%
0.00%
Q4 2014$228,00013,6540.00%
Other shareholders

There were no reported owners of VITAE PHARMACEUTICALS INC in Q3 2016.

NameSharesValueWeighting ↓
View complete list of VITAE PHARMACEUTICALS INC shareholders